Abstract
DSS induced colitis is a chronic inflammatory disease characterized by inflammation in the gastrointestinal tract, which destabilizes the gut and induces an uncontrolled immune response. Although DSS induced colitis is generally thought to develop as a result of an abnormally active intestinal immune system, its pathogenesis remains unclear. Gene associated with retinoid interferon induced mortality (Grim) 19 is an endogenous specific inhibitor of STAT3, which regulates the expression of proinflammatory cytokines. In this study, we investigated the influence of GRIM19 in a DSS induced colitis mouse model. We hypothesized that Grim19 would ameliorate DSS induced colitis by altering STAT3 activity and intestinal inflammation. Grim19 ameliorated DSS induced colitis severity and protected intestinal tissue. The expression of STAT3 and proinflammatory cytokines such as IL-1β and TNF-α in colon and lymph nodes was decreased significantly by Grim19. Moreover, DSS induced colitis progression in a Grim19 transgenic mouse line was inhibited in association with a reduction in STAT3 and IL-17 expression. These results suggest that Grim19 attenuates DSS induced colitis by suppressing the excessive inflammatory response mediated by STAT3 activation.
MeSH terms
-
Animals
-
Colitis / chemically induced
-
Colitis / genetics
-
Colitis / metabolism*
-
Colitis / pathology
-
Colon / metabolism*
-
Colon / pathology
-
Dextran Sulfate
-
Disease Models, Animal
-
Inflammation / metabolism
-
Inflammation / pathology
-
Interleukin-17 / metabolism
-
Interleukin-1beta / metabolism
-
Lymph Nodes / metabolism*
-
Lymph Nodes / pathology
-
Mice
-
Mice, Inbred C57BL
-
Mice, Transgenic
-
NADH, NADPH Oxidoreductases / genetics
-
NADH, NADPH Oxidoreductases / metabolism*
-
STAT3 Transcription Factor / metabolism
-
Tumor Necrosis Factor-alpha / metabolism
Substances
-
Interleukin-17
-
Interleukin-1beta
-
STAT3 Transcription Factor
-
Tumor Necrosis Factor-alpha
-
Dextran Sulfate
-
NADH, NADPH Oxidoreductases
-
Grim19 protein, mouse
Grants and funding
This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (
https://www.khidi.or.kr/) (HI15C1062). This study was also supported by a grant of the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (HI14C3417); and a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C0016).